Literature DB >> 21885838

Mechanism of antiarrhythmic effects of flecainide in catecholaminergic polymorphic ventricular tachycardia.

Hiroshi Watanabe, Derek S Steele, Björn C Knollmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21885838     DOI： 10.1161/CIRCRESAHA.111.251322

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  8 in total

1.  Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Derek S Steele; Hyun-Seok Hwang; Björn C Knollmann
Journal:  Cardiovasc Res       Date:  2013-03-19       Impact factor: 10.787

2.  Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventricles.

Authors:  Young Soo Lee; Mitsunori Maruyama; Po Cheng Chang; Hyung Wook Park; Kyoung-Suk Rhee; Yu-Cheng Hsieh; Chia-Hsiang Hsueh; Changyu Shen; Shien-Fong Lin; Hyun Seok Hwang; Huiyong Yin; Björn C Knollmann; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

3.  Xanthohumol Modulates Calcium Signaling in Rat Ventricular Myocytes: Possible Antiarrhythmic Properties.

Authors:  Juan Jose Arnaiz-Cot; Lars Cleemann; Martin Morad
Journal:  J Pharmacol Exp Ther       Date:  2016-11-04       Impact factor: 4.030

4.  High-dose flecainide with low-dose β-blocker therapy in catecholaminergic polymorphic ventricular tachycardia: A case report and review of the literature.

Authors:  Johannes Steinfurt; Markus-Johann Dechant; Doris Böckelmann; Sven Zumhagen; Brigitte Stiller; Eric Schulze-Bahr; Christoph Bode; Katja E Odening
Journal:  J Cardiol Cases       Date:  2014-09-26

5.  RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.

Authors:  Dmytro O Kryshtal; Daniel J Blackwell; Christian L Egly; Abigail N Smith; Suzanne M Batiste; Jeffrey N Johnston; Derek R Laver; Bjorn C Knollmann
Journal:  Circ Res       Date:  2020-12-10       Impact factor: 17.367

6.  In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Pei-Chi Yang; Jonathan D Moreno; Christina Y Miyake; Steven B Vaughn-Behrens; Mao-Tsuen Jeng; Eleonora Grandi; Xander H T Wehrens; Sergei Y Noskov; Colleen E Clancy
Journal:  J Physiol       Date:  2015-12-30       Impact factor: 5.182

Review 7.  Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges.

Authors:  Márcia Vagos; Ilsbeth G M van Herck; Joakim Sundnes; Hermenegild J Arevalo; Andrew G Edwards; Jussi T Koivumäki
Journal:  Front Physiol       Date:  2018-09-04       Impact factor: 4.566

8.  New antiarrhythmic targets to control intracellular calcium handling.

Authors:  H E Driessen; V J A Bourgonje; T A B van Veen; M A Vos
Journal:  Neth Heart J       Date:  2014-05       Impact factor: 2.380
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.